NGS Based Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global NGS Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type DNA Sequencing RNA Sequencing Whole Genome Sequencing Whole Exome Sequencing Other Segment by Application Hospitals Clinics Academics/Research Institutions By Company Janssen Roche Qiagen ThermoFisher Scientific Oxford Gene Technology Illumina Pacific Biosciences Paradigm Diagnostics Innogene Kalbiotech Admera Health AITbiotech Centogene Phalanx Biotech Group iGenomX By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global NGS Based Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 DNA Sequencing 1.2.3 RNA Sequencing 1.2.4 Whole Genome Sequencing 1.2.5 Whole Exome Sequencing 1.2.6 Other 1.3 Market by Application 1.3.1 Global NGS Based Diagnostic
